Literature DB >> 19558781

Myoblast transfer in ischemic heart failure: effects on rhythm stability.

Warren Sherman1, Kun-Lun He, Geng-Hua Yi, Jie Wang, Jack Harvey, Myung J Lee, Howard Haimes, Paul Lee, Emma Miranda, Sunil Kanwal, Daniel Burkhoff.   

Abstract

Skeletal myoblast (SM) implantation promotes recovery of myocardial function after ischemic injury. Clinical observations suggest an association of SM implantation and ventricular arrhythmias. Support for this link has been sought in animal studies, but none employing models of congestive heart failure. In a canine model of postinfarction congestive heart failure (CHF) we compared the frequency of rhythm disturbances using ambulatory electrocardiography monitoring following skeletal myoblast or saline (SAL) implantation. In 19 mongrel dogs ischemic injury and CHF were induced by intracoronary microsphere infusions. Direct intramyocardial injection of autologous skeletal myoblasts (ASM) (2.7-8.3 x 10(8) cells) or SAL controls was administered to 11 and 8 dogs, respectively. Serial echocardiography and 24-h ambulatory electrocardiography were recorded at baseline (after CHF induction) and at 4 weeks and at 8-10 weeks after injection. Comparisons between groups of left ventricular ejection fraction (LVEF) and the frequency of ventricular arrhythmias, supraventricular arrhythmias, and measures of heart rate variability (HRV) were made at each of the three time points. LVEF increased from 41 +/- 6% to 47 +/- 2% (p < 0.03) in the ASM group, and did not change (42 +/- 6% to 40 +/- 2%, p = ns) in SAL. After injection, no differences were seen in the number of dogs demonstrating ventricular tachycardia (n = 3 vs. n = 2, p = ns) or frequent PVCs (n = 3 vs. n = 3, p = ns) in the ASM versus SAL groups, respectively. Significant changes were observed in a time-domain measure of HRV, standard deviation of normal-to-normal RR interval (in ms: 4 weeks 174 +/- 95 vs. 242 +/- 19; 8 weeks 174 +/- 78 vs. 276 +/- 78, ASM vs. SAL), but not in other time domain parameters. In this canine model of ischemic CHF, ASM implantation did not result in a significant increase in ventricular arrhythmias compared to controls animals. The potential for ASM implantation to affect time-domain parameters of HRV merits further study.

Entities:  

Mesh:

Year:  2009        PMID: 19558781     DOI: 10.3727/096368909788534933

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  5 in total

1.  Exogenous connexin43-expressing autologous skeletal myoblasts ameliorate mechanical function and electrical activity of the rabbit heart after experimental infarction.

Authors:  Ieva Antanavičiūtė; Eglė Ereminienė; Vaidas Vysockas; Mindaugas Račkauskas; Vilius Skipskis; Kristina Rysevaitė; Rimantas Treinys; Rimantas Benetis; Jonas Jurevičius; Vytenis A Skeberdis
Journal:  Int J Exp Pathol       Date:  2014-12-22       Impact factor: 1.925

Review 2.  Skeletal myoblasts for cardiac repair.

Authors:  Shazia Durrani; Mikhail Konoplyannikov; Muhammad Ashraf; Khawaja Husnain Haider
Journal:  Regen Med       Date:  2010-11       Impact factor: 3.806

3.  Stem/Progenitor cells, atherosclerosis and cardiovascular regeneration.

Authors:  Olena Dotsenko
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

4.  Fate of modular cardiac tissue constructs in a syngeneic rat model.

Authors:  Brendan M Leung; Yasuo Miyagi; Ren-Ke Li; Michael V Sefton
Journal:  J Tissue Eng Regen Med       Date:  2013-03-15       Impact factor: 3.963

5.  Isolation of myogenic stem cells from cultures of cryopreserved human skeletal muscle.

Authors:  Bo Zheng; Chien-Wen Chen; Guangheng Li; Seth D Thompson; Minakshi Poddar; Bruno Péault; Johnny Huard
Journal:  Cell Transplant       Date:  2012-04-02       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.